Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhisa Inoue

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Scientific Reports|July 25, 2022
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutationMasanori Sawamura, Keiko Imamura, Rie Hikawa, et al.
Scientific Reports|August 11, 2017
TDP-43 stabilises the processing intermediates of mitochondrial transcriptsKeiichi Izumikawa, Yuko Nobe, Harunori Yoshikawa, et al.
Neuroscience Research|September 25, 2007
Pael receptor is involved in dopamine metabolism in the nigrostriatal systemYuzuru Imai, Haruhisa Inoue, Ayane Kataoka, et al.
Molecular Brain|March 20, 2020
Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel diseaseYumi Yamamoto, Katsutoshi Kojima, Daisuke Taura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 3, 2016
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural ProgenitorsBin Ji, Hiroyuki Kaneko, Takafumi Minamimoto, et al.
Scientific Reports|May 14, 2022
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2Naohiro Egawa, Yuishin Izumi, Hidefumi Suzuki, et al.
Scientific Reports|October 11, 2016
Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neuronsKeiko Imamura, Naruhiko Sahara, Nicholas M Kanaan, et al.
Eclinicalmedicine|December 5, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trialKeiko Imamura, Yuishin Izumi, Makiko Nagai, et al.
NPJ Vaccines|March 29, 2020
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model miceHiroki Takeuchi, Keiko Imamura, Bin Ji, et al.
JCI Insight|April 22, 2024
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunctionYuki Otsuka, Keiko Imamura, Akio Oishi, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Scientific Reports|July 25, 2022
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutationMasanori Sawamura, Keiko Imamura, Rie Hikawa, et al.
Scientific Reports|August 11, 2017
TDP-43 stabilises the processing intermediates of mitochondrial transcriptsKeiichi Izumikawa, Yuko Nobe, Harunori Yoshikawa, et al.
Neuroscience Research|September 25, 2007
Pael receptor is involved in dopamine metabolism in the nigrostriatal systemYuzuru Imai, Haruhisa Inoue, Ayane Kataoka, et al.
Molecular Brain|March 20, 2020
Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel diseaseYumi Yamamoto, Katsutoshi Kojima, Daisuke Taura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 3, 2016
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural ProgenitorsBin Ji, Hiroyuki Kaneko, Takafumi Minamimoto, et al.
Scientific Reports|May 14, 2022
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2Naohiro Egawa, Yuishin Izumi, Hidefumi Suzuki, et al.
Scientific Reports|October 11, 2016
Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neuronsKeiko Imamura, Naruhiko Sahara, Nicholas M Kanaan, et al.
Eclinicalmedicine|December 5, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trialKeiko Imamura, Yuishin Izumi, Makiko Nagai, et al.
NPJ Vaccines|March 29, 2020
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model miceHiroki Takeuchi, Keiko Imamura, Bin Ji, et al.
JCI Insight|April 22, 2024
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunctionYuki Otsuka, Keiko Imamura, Akio Oishi, et al.
Pageof 14